InvestorsHub Logo
Followers 129
Posts 3809
Boards Moderated 0
Alias Born 07/12/2003

Re: None

Friday, 01/27/2023 12:30:07 PM

Friday, January 27, 2023 12:30:07 PM

Post# of 198711
Biopharma buyers continue to shift deal-making spending away from M&A
10-Jan-2022 By Jane Byrne

Strategic partnerships rather than M&A will be key for biopharma companies in 2022, finds a report from EY.

HTTPS://WWW.BIOPHARMA-REPORTER.COM/ARTICLE/2022/01/10/BIOPHARMA-BUYERS-CONTINUE-TO-SHIFT-DEAL-MAKING-SPENDING-AWAY-FROM-M-A
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENZC News